Carlos COITO
Inventor
Stats
- 16 US patents issued
- 38 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 16 US Patents Issued
- 38 US Applications Filed
- 105 Total Citation Count
- May 29, 2020 Most Recent Filing
- Dec 2, 2009 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| OPKO CURNA, LLC | 2
| 2010
|
| CURNA, INC. | 1
12 9 2 3 12 3 4 | 2009
2010 2011 2013 2014 2015 2016 2017 |
| The Scripps Research Institute | 1
1 | 2013
2017 |
Inventor Addresses
| Address | Duration |
|---|---|
| WEST PALM BEACH, FL, US | Jun 04, 15 - Jun 04, 15 |
| West Palm Beach, FL, US | Nov 04, 10 - Aug 09, 22 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 29 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 10 |
| A61Q: | USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 11408004 | 2022 | Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT) | 0 |
| 11390868 | 2022 | Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity | 0 |
| 10995334 | 2021 | Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2 | 0 |
| 10793857 | 2020 | Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNA | 1 |
| 2020/0291,407 | 2020 | TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.